Compare ORMP & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | CFBK |
|---|---|---|
| Founded | 2002 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.3M | 178.1M |
| IPO Year | 2010 | 2005 |
| Metric | ORMP | CFBK |
|---|---|---|
| Price | $4.32 | $35.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $31.50 |
| AVG Volume (30 Days) | ★ 171.6K | 61.7K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 6.51% | 1.23% |
| EPS Growth | ★ 412.50 | 30.58 |
| EPS | ★ 0.91 | 0.77 |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | $31.99 |
| Revenue Next Year | N/A | $9.09 |
| P/E Ratio | ★ $4.90 | $46.23 |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $22.10 |
| 52 Week High | $5.19 | $36.95 |
| Indicator | ORMP | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 70.14 |
| Support Level | $3.90 | $32.20 |
| Resistance Level | $5.10 | $36.95 |
| Average True Range (ATR) | 0.18 | 1.01 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 79.24 | 69.55 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.